Clinical Trials Logo

Filter by:
NCT ID: NCT04927611 Recruiting - Clinical trials for Neuroendocrine Neoplasm

Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm

Start date: June 6, 2021
Phase:
Study type: Observational

The aim of this study is to use single-cell sequencing technology to explore neuroendocrine neoplasm (NEN) molecular biological characteristics, tumor heterogeneity and cell subtypes. Besides. NEN models are constructed for basic research, including primary cell lines, organoids, and animal models.

NCT ID: NCT04927520 Recruiting - Clinical trials for Middle Cerebral Artery Aneurysm

Prospective, Multicenter Cohort Study on the Safety and Efficacy of Treatment for Middle Cerebral Artery Aneurysms

Start date: June 5, 2021
Phase:
Study type: Observational [Patient Registry]

Intracranial aneurysm is one of the most common cerebrovascular diseases, with a prevalence of about 3.2%. With the aging of the population and the further popularization of MRA and other examination methods, the prevalence of intracranial aneurysm will further increase. Rupture of intracranial aneurysm is an important cause of death and severe disability in patients. The annual rate of rupture of intracranial aneurysm is about 1%, and the size of aneurysm, the location of aneurysm in the posterior circulation, and the history of subarachnoid hemorrhage on the aneurysm wall are the risk factors for aneurysm rupture. Phases are currently recognized tools for assessing the risk of aneurysm rupture, which can provide important guidance for neurosurgeons and patients to decide whether to actively intervene. In the last century, for patients with intracranial aneurysm with high risk of rupture, craniotomy and clipping for intracranial aneurysm was the gold standard for treatment. However, with the rapid development of embolization technology and materials in the past 20 years, the application of endovascular embolization for intracranial aneurysms has been more and more widely, especially after several large prospective studies such as ISAT and ISUIA, endovascular embolization has more advantages over craniotomy clipping.Whereas, it is still very popular to adopt craniotomy clipping for middle cerebral artery aneurysms, the main reasons for which are relative superficial location, wider aneurysm neck, smaller parent artery and more branching vessels, etc., which make early endovascular embolization treatment not advantageous. With the maturity of stent-assisted embolization technology in recent years, the use of a new generation of stents, and the improvement of perioperative anti-platelet strategies, endovascular embolization has achieved good results in the treatment of middle artery aneurysms. However, these studies were retrospective, single-center studies, subject to a variety of confounding factors, and the reliability of the results is limited. Therefore, it will be of great clinical significance to carry out a prospective, multi-center clinical study on the treatment strategy of middle cerebral artery aneurysms. Patients with unruptured middle cerebral artery aneurysms who had been diagnosed with at least one imaging (CTA/MRA/DSA)were enrolled. The treatment including endovascular embolization and craniotomy clipping was determined according to routine management in the center. After receiving informed consent from the patients, the safety and effectiveness data were obtained to verify whether endovascular embolization was safe and effective. Through further follow-up and data analysis, protective factors and risk factors for the treatment of middle cerebral artery aneurysms were investigated. Through well-designed clinical studies, safer and more effective treatment methods can be found, and potential factors leading to perioperative complications can be found, ultimately improving the prognosis of patients with middle cerebral artery aneurysms.

NCT ID: NCT04927507 Recruiting - Clinical trials for Rotator Cuff Injuries

Rotator Cuff Injury Managed With ERAS and Internet Plus Nursing

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Rotator cuff injury patients treated with ERAS were included. The control group was given routine nursing. The observation group was given the Internet plus nursing home rehabilitation mode. Relying on mobile app and wechat, patients can get online guidance of rehabilitation training video through app and wechat, and get professional rehabilitation guidance at any time.

NCT ID: NCT04927117 Recruiting - Cataract Clinical Trials

Evaluation of Visual Acuity in Myopic Cataract Patients Using Trifocal Intraocular Lens

Start date: July 1, 2020
Phase:
Study type: Observational

The PanOptix trifocal IOL is a new trifocal intraocular lens which is proved to provide good range of vision for distance, intermediate and near and good visual quality in cataract patients with normal axial length. But whether it can get the same visual quality in myopia is still unknown

NCT ID: NCT04927000 Recruiting - Clinical trials for Rheumatoid Arthritis

The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis

Start date: May 31, 2021
Phase: Phase 4
Study type: Interventional

Rheumatoid arthritis (RA) is a systemic chronic arthritis characterized by systemic inflammation, persistent synovitis and final joint destruction Inflammatory diseases can lead to decreased productivity and impaired health-related quality of life. As a chronic disease, rheumatoid Chronic arthritis needs long-term treatment. At the same time, RA can cause skin, eye, lung, liver, kidney, blood and cardiovascular diseases All of them were extraarticular lesions. It causes a heavy burden to the patients themselves, their families and the society. The main clinical manifestations of RA were morning stiffness Joint swelling and pain, cartilage destruction and joint space narrowing, if not treated, will lead to joint destruction, deformity and dysfunction The rate of disability is high. As a new drug in the treatment of RA, tofacitinib can relieve RA symptoms and promote joint healing It can recover the injury and correct the abnormal immune function. At present, studies have proved that the traditional anti rheumatic drugs are ineffective in the treatment of RA. The addition of tofacitinib to patients may be beneficial to the treatment.

NCT ID: NCT04926987 Recruiting - Aging Clinical Trials

The Research of Human Cortex Cell Atlas

Start date: June 1, 2020
Phase:
Study type: Observational

In this study, the single-cell transcriptome sequencing technology was used to study the transcriptome differences at the single-cell level in normal human brain, aging human brain, and epileptic brain.

NCT ID: NCT04926909 Recruiting - Parkinson's Disease Clinical Trials

Study on Serum Cystatin C and PET-DAT in Patients With Parkinson's Disease

Start date: July 1, 2020
Phase:
Study type: Observational [Patient Registry]

To investigate the relationship between serum cystatin C and dopamine receptor(DAT) loss in patients with parkinson's disease(PD)

NCT ID: NCT04926896 Recruiting - Control Group Clinical Trials

Evaluation of Minimally Invasive Ilium Osteotomy and Its Bone Repairing Effect

Start date: September 20, 2020
Phase: N/A
Study type: Interventional

In this research, a new bone harvesting technique is introduced in order to find an iliac crest bone harvesting method for patients with less trauma, less postoperative pain in donor sites, and lower incidence of postoperative complications, so as to get ideal bone grafting materials at a small cost, enhance the effect of osteogenesis repair on bone defect or fusion site, and improve the operation quality.

NCT ID: NCT04926870 Recruiting - Case Based Learning Clinical Trials

PACS System in the Training of Ophthalmologists

Start date: June 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate teaching effect of CBL (case based learning) teaching method based on PACS (picture archiving and communication systems).

NCT ID: NCT04926766 Recruiting - Breast Cancer Clinical Trials

Super Hypofractionated Irradiation For Whole Breast Treatment

SHIFT
Start date: January 23, 2021
Phase: N/A
Study type: Interventional

The purpose of this trial is to investigate the safety and efficacy of super hypofractionated whole breast irradiation (SHF-WBI) in breast cancer patients treated with breast conserving surgery. Eligible breast cancer patients will be followed for at least 5 years to evaluate the acute and late radiation-induced toxicities, locoregional recurrence, distant metastasis, death, contralateral breast cancer and quality of life.